Michael J. Curren

Michael Curren practices at UPMC St. Margaret in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Michael Curren's NPI, 1225221237, was assigned on August 22, 2007. Michael Curren holds Pennsylvania license MD439934.

Michael Curren's primary practice is UPMC St. Margaret, at 815 Freeport Road, Pittsburgh, PA 15215 in Allegheny County. The practice phone is (412) 784-4000.

Michael Curren's primary practice is UPMC St. Margaret in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Michael Curren is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Michael Curren to 2 more hospitals, 2 group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Curren practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Michael Curren's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Michael Curren is licensed in Pennsylvania.

CMS data shows 1,334 Medicare services from Michael Curren across 17 procedure codes in 2024, for 889 Medicare patients. Medicare paid $45,249 for them.

CMS counts 889 Medicare patients who saw Michael Curren in 2024. The largest group is 65 to 74, with 363 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Curren's median patient age at 73, with 43% women.

In 2024, Michael Curren wrote 4,685 Medicare Part D claims for 636 patients. 72% of them were for generic drugs. CMS names the drug for 4,488 of them, across 42 drugs with 11 or more claims each, at $1,181,969 in total drug cost. In 2023, CMS named 4,121 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Michael Curren for performance year 2024, reported as part of a group. Michael Curren accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 27 general payments to Michael Curren from 9 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $70.